『Ryjunea Approved in the UK for Myopia』のカバーアート

Ryjunea Approved in the UK for Myopia

Ryjunea Approved in the UK for Myopia

無料で聴く

ポッドキャストの詳細を見る

このコンテンツについて

Sydnexis receives another regulatory approval for its childhood myopia eye drop; Eli Lilly makes two major investments in ophthalmology; and Nanoscope reports new long-term data for its intravitreal optogenetic therapy for RP. Learn more about your ad choices. Visit megaphone.fm/adchoices
まだレビューはありません